In clinical studies, Rebinyn® was shown to be safe and effective, with 0 inhibitors and blood clots.
DESIGNED FOR SAFETY
The safety of Rebinyn® has been clinically studied over 8801 exposure days, and it is manufactured to
All images of hemophilia B patients shown are for illustrative purposes only.
All images of hemophilia B patients shown for illustrative purposes only.